VAXIGRIPTETRA susp inj 2024/2025 ser pré 0.5 ml
7680664270273
CH-66427
J07BB02
08.08.
Reimbursement limitations:
0808 NEU
La prise en charge des coûts des vaccins au titre de mesure préventive dans le …
1 / 3
google
Details
- Product number
- 6642708
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- haemagglutininum influenzae A (H1N1) (Virus souche A/Victoria/4897/2022 (H1N1)pdm09-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022) 15 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Thailand/8/2022 (H3N2)-like: derived from A/California/122/2022, SAN-022) 15 µg, haemagglutininum influenzae B (Virus souche B/Austria/1359417/2021-like: B/Michigan/01/2021, wilde type (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus souche B/Phuket/3073/2013-like: B/Phuket/3073/2013, wilde type (Yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.72 mg, kalium 0.08 mg, residui: formaldehydum, octoxinolum-9, neomycinum, ovalbuminum.
Articles (1)
VaxigripTetra, Suspension pour injection dans une seringue pré-remplie
suspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.72 MG | Substance | HBESI |
|
(N/A)
|
0.08 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | RESI |
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 66427
- Drug name
- VaxigripTetra, Suspension pour injection dans une seringue pré-remplie
- Galenic form
- SUPA
- ATC Code
- J07BB02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 12/06/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VAXIGRIPTETRA susp inj 2024/2025 ser pré 0.5 ml
- Description (DE)
- VAXIGRIPTETRA Inj Susp 2024/2025 Fertspr 0.5 ml
- Market launch
- 01/08/2024
- Narcotic (BTM)
- No